Related documents Search history  |  Help

[ clip Unanimous Supreme Court preserves access to widely used abortion medication ]

5 document(s) related     Misc. items: 5

Legal Documents
Clips
Alliance for Hippocratic Medicine, et al., v. U.S. Food and Drug Administration, et al., v. Danco Laboratories, LLC; Opinion (No. 23-10362, restoring U.S. Food and Drug Administration's mifepristone approval but upholding lower court's block of new FDA regulations broadening access to the drug; abortion medication). (Link Type: Federal Court Case)
See: https://lrl.texas.gov/scanned/archive/2023/52069.pdf
By U.S. Court of Appeals for the Fifth Circuit
Publication Date: August 16, 2023
  14
Alliance for Hippocratic Medicine, et al., v. U.S. Food and Drug Administration, et al.; Memorandum opinion and order (No. 2:22-CV-00223-Z, suspending FDA's approval of mifepristone, contending the agency lacked legal authority to approve and enable access, and blocking new FDA regulations broadening access to the drug; abortion medication). (Link Type: Federal Court Case)
See: https://s3.documentcloud.org/documents/23746119/read-texas-federal-judge-ruling-on-abortion-pill.pdf
By U.S. District Court for the Northern District of Texas, Amarillo Division
Publication Date: April 7, 2023
  31
Food and Drug Administration, et al., v. Alliance for Hippocratic Medicine, et al., and Danco Laboratories, LLC v. Alliance for Hippocratic Medicine, et al.; Opinion (Nos. 23-235 and 23-236, plaintiff's lack standing to challenge FDA's actions regarding regulation of mifepristone). (Link Type: Federal Court Case)
See: https://www.supremecourt.gov/opinions/23pdf/23-235_n7ip.pdf
By U.S. Supreme Court
Publication Date: June 13, 2024
  8
State of Idaho v. United States; Docket (No. 23-727, whether the Emergency Medical Treatment and Labor Act (EMTALA) trumps Idaho's Defense of Life Act; abortion). (Link Type: Federal Court Case)
See: https://www.supremecourt.gov/search.aspx?filename=/docket/docketfiles/html/public/23-727.html
By U.S. Supreme Court
Publication Date: January 5, 2024
  9
State of Missouri, et al., v. U.S. Food and Drug Administration, et al.; Complaint (No. 2:22-cv-00223-Z, states of Missouri, Kansas, and Idaho, which have standing that plaintiff doctors lack, intervening and challenging FDA's approval to provide mifepristone access). (Link Type: Federal Court Case)
See: https://storage.courtlistener.com/recap/gov.uscourts.txnd.370067/gov.uscourts.txnd.370067.176.0_1.pd...
By U.S. District Court for the Northern District of Texas, Amarillo Division
Publication Date: January 12, 2024
  4